Education
About Us
Working with TipRanks
Follow Us
Symbio Pharmaceuticals Limited (JP:4582)
:4582
RESEARCH TOOLSreports
4582 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥126.00 - ¥475.00
Previous CloseN/A
Volume447.50K
Average Volume (3M)370.87K
Market Cap
¥8.68B
Enterprise ValueN/A
Total Cash (Recent Filing)¥3.96B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Jul 31, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-27.95
Shares Outstanding48,816,505
10 Day Avg. Volume355,090
30 Day Avg. Volume370,866
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)1.88
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Symbio Pharmaceuticals Limited News
PremiumCompany Announcements
SymBio Pharmaceuticals Reports Significant Q1 2025 Losses
PremiumCompany Announcements
SymBio Pharmaceuticals Reports Significant Financial Decline in FY 2024
PremiumCompany Announcements
SymBio Pharmaceuticals Faces Financial Decline
PremiumCompany Announcements
Symbio Pharmaceuticals Faces Steep Decline in H1 FY2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.88% Public Companies and
Individual Investors
4582 FAQ
What was Symbio Pharmaceuticals Limited’s price range in the past 12 months?
Symbio Pharmaceuticals Limited lowest stock price was ¥126.00 and its highest was ¥475.00 in the past 12 months.
What is Symbio Pharmaceuticals Limited’s market cap?
Symbio Pharmaceuticals Limited’s market cap is ¥8.68B.
When is Symbio Pharmaceuticals Limited’s upcoming earnings report date?
Symbio Pharmaceuticals Limited’s upcoming earnings report date is Jul 31, 2025 which is in 69 days.
How were Symbio Pharmaceuticals Limited’s earnings last quarter?
Symbio Pharmaceuticals Limited released its earnings results on May 08, 2025. The company reported -¥27.95 earnings per share for the quarter, missing the consensus estimate of N/A by -¥27.95.
Is Symbio Pharmaceuticals Limited overvalued?
According to Wall Street analysts Symbio Pharmaceuticals Limited’s price is currently Overvalued.
Does Symbio Pharmaceuticals Limited pay dividends?
Symbio Pharmaceuticals Limited does not currently pay dividends.
What is Symbio Pharmaceuticals Limited’s EPS estimate?
Symbio Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Symbio Pharmaceuticals Limited have?
Symbio Pharmaceuticals Limited has 48,816,505 shares outstanding.
What happened to Symbio Pharmaceuticals Limited’s price movement after its last earnings report?
Symbio Pharmaceuticals Limited reported an EPS of -¥27.95 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.637%.
Which hedge fund is a major shareholder of Symbio Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in JP:4582
Company Description
Symbio Pharmaceuticals Limited
Symbio Pharmaceuticals Limited (4582) is a specialized pharmaceutical company focused on the development, manufacturing, and distribution of innovative healthcare solutions. The company operates within the biotechnology and pharmaceutical sectors, offering a portfolio of prescription medications, over-the-counter drugs, and advanced therapeutic treatments. Symbio Pharmaceuticals is committed to advancing patient care by providing high-quality and accessible medical options tailored to various health conditions.
Technical Analysis
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Eisai Co
―
Takeda Pharmaceutical Co
―
Daiichi Sankyo Company
―